Susannah Cantrell
Corporate Officer/Principal bei BRII BIOSCIENCES LIMITED
Profil
Susannah Cantrell is currently the Chief Business Officer at Brii Biosciences Ltd.
(China) since 2022.
Prior to this, she worked as the VP & Head-Global Commercial Strategy at Gilead Sciences, Inc. from 2011 to 2019.
She was also the Chief Commercial Officer & Executive VP at Tricida, Inc. in 2020.
Dr. Cantrell held the position of Head-Sales & Marketing at GlaxoSmithKline LLC and was the Chief Operating & Business Officer at Second Genome, Inc. She holds a doctorate degree from the University of Missouri and an undergraduate degree from Westminster College (Pennsylvania).
Aktive Positionen von Susannah Cantrell
| Unternehmen | Position | Beginn |
|---|---|---|
| BRII BIOSCIENCES LIMITED | Corporate Officer/Principal | 11.07.2022 |
Ehemalige bekannte Positionen von Susannah Cantrell
| Unternehmen | Position | Ende |
|---|---|---|
| TRICIDA, INC. | Corporate Officer/Principal | 30.10.2020 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01.01.2019 |
Second Genome, Inc.
 Second Genome, Inc. BiotechnologyHealth Technology Second Genome, Inc. develops microbiome-based therapeutic products. It offers phyclochip community, 16S sequencing community analysis, whole metagenomic profiling, nucleic acid isolation, inferred function and custom informatics services. The company was founded in 2009 by Corey S. Goodman, Janet A. Warrington, Todd Z. DeSantis, John Hulls and Gary Andersen and is headquartered in South San Francisco, CA. | Geschäftsführer | - |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Vertrieb & Marketing | - |
Ausbildung von Susannah Cantrell
| Westminster College (Pennsylvania) | Undergraduate Degree |
| University of Missouri | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| TRICIDA, INC. | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
| BRII BIOSCIENCES LIMITED | Commercial Services |
| Private Unternehmen | 2 |
|---|---|
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
Second Genome, Inc.
Second Genome, Inc. BiotechnologyHealth Technology Second Genome, Inc. develops microbiome-based therapeutic products. It offers phyclochip community, 16S sequencing community analysis, whole metagenomic profiling, nucleic acid isolation, inferred function and custom informatics services. The company was founded in 2009 by Corey S. Goodman, Janet A. Warrington, Todd Z. DeSantis, John Hulls and Gary Andersen and is headquartered in South San Francisco, CA. | Health Technology |
